Delivery Order SPE2DB22D2206-SPE2DB24FKB13
Award Date
8/29/24
Potential Completion Date
9/20/24
Potential Value
$24K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of pharmaceutical products, including the drug TIVDAK 40 MG VIALS. The award has a ceiling value of $27,898.01 and a completion date of November 13, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product TIVDAK 40 MG VIALS to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of July 22, 2024 and a ceiling value of $23,912.58. It is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FVM13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,083.75 firm fixed-price delivery order is for the supply of 4,568,078,648 units of the drug TIVDAK 40 MG VIALS. The contract has a period of performance through May 20, 2025 and is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of TIVDAK 40 MG VIALS, a pharmaceutical product, to support military healthcare programs. The $13,083.75 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $13,083.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for the supply of TIVDAK 40 MG VIALS, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. It is associated with a larger Indefinite Delivery Contract (IDC) worth $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $11,956.29 firm fixed-price delivery order is for the supply of 40 mg vials of the drug TIVDAK. The contract does not have a set-aside designation and has an ultimate completion date of July 22, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TIVDAK 40 MG VIALS, a pharmaceutical product, with a firm fixed price of $13,083.75 and a completion date of April 23, 2025. The contract is not set-aside and represents open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,628.10 firm fixed-price delivery order is for the supply of TDVAX VIAL 0.5ML medical products. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $1,526.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TDVAX VIAL 0.5ML medical supplies, with an ultimate completion date of September 29, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,963.18 firm fixed-price delivery order is for the supply of 'TALVEY 40 MG/ML VIALML' medical products. The contract has an ultimate completion date of March 6, 2025 and is not set aside for any specific business category. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...